Additionally, the role of widespread clinical testing for GPVs in other BC-risk genes, such as CDH1, STK11 and PTEN that increase the risk for BC in the context of Hereditary Diffuse Gastric Cancer, Peutz-Jeghers and Cowden’s syndrome, respectively, continues to be debated (9). The gene discussed is CDH1; the disease is breast cancer.